What are the MAOIs listed in antidepressant treatments?

The correct answer includes Isocarboxazid, Tranylcypromine, and Phenelzine, which are all classified as monoamine oxidase inhibitors (MAOIs). MAOIs are a specific type of antidepressant that work by inhibiting the action of the monoamine oxidase enzyme, leading to increased levels of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. This mechanism can be particularly effective in treating certain mood disorders, including atypical depression and treatment-resistant depression.

Understanding the function and classification of these medications is crucial. Isocarboxazid, Tranylcypromine, and Phenelzine are among the few MAOIs that are commonly prescribed, and they require careful management due to potential interactions with certain foods and other medications, which can lead to hypertensive crises.

The other choices include medications that belong to different classes of antidepressants. Nortriptyline, Fluoxetine, Sertraline, Duloxetine, Desvenlafaxine, and Bupropion are not MAOIs; instead, they represent tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs), along with norepinephrine and dopamine reuptake inhibitors. Understanding